Challenges for metals in medicine: How nanotechnology may help to shape the future

ACS Nano

Volumn 7, Issue 7, 2013, Pages 5654-5659

  Barry, Nicolas P E ^a   Sadler, Peter J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION MECHANISMS; ANTICANCER DRUG; BLOCK-COPOLYMER NANOPARTICLES; CIRCULATION TIME; CONTROLLED DRUG RELEASE; LIGAND SUBSTITUTION; METAL COORDINATION; REDOX PROPERTY;

DRUG PRODUCTS; LIGANDS;

NANOPARTICLES;

DRUG; METAL NANOPARTICLE; NANOCAPSULE;

CHEMISTRY; FORECASTING; NANOMEDICINE; TRENDS; ARTICLE;

FORECASTING; METAL NANOPARTICLES; NANOCAPSULES; NANOMEDICINE; PHARMACEUTICAL PREPARATIONS;

EID: 84880786102     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn403220e     Document Type: Review

References (25)

1. Barry, N. P. E.; Sadler, P. J. Exploration of the Medical Periodic Table: Towards New Targets Chem. Commun. 2013, 49, 5106-5131
2. Graf, N.; Lippard, S. J. Redox Activation of Metal-Based Prodrugs as a Strategy for Drug Delivery Adv. Drug Delivery Rev. 2012, 64, 993-1004
3. Braddock, P. D.; Connors, T. A.; Jones, M.; Khokhar, A. R.; Melzack, D. H.; Tobe, M. L. Structure and Activity Relations of Platinum Complexes with Antitumor Activity Chem. Biol. Interact. 1975, 11, 145-161
4. Bonomi, P. D.; Finkelstein, D. M.; Ruckdeschel, J. C.; Blum, R. H.; Green, M. D.; Mason, B.; Hahn, R.; Tormey, D. C.; Harris, J.; Comis, R. Combination Chemotherapy Versus Single Agents Followed by Combination Chemotherapy in Stage IV Non-Small-Cell Lung Cancer: A Study of the Eastern Cooperative Oncology Group J. Clin. Oncol. 1989, 7, 1602-1613
5. Dhar, S.; Lippard, S. J. Mitaplatin, a Potent Fusion of Cisplatin and the Orphan Drug Dichloroacetate Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 22199-22204
6. Farokhzad, O. C.; Langer, R. Impact of Nanotechnology on Drug Delivery ACS Nano 2009, 3, 16-20
7. Gref, R.; Minamitake, Y.; Peracchia, M. T.; Trubetskoy, V.; Torchilin, V.; Langer, R. Biodegradable Long-Circulating Polymeric Nanospheres Science 1994, 263, 1600-1603
8. Jokerst, J. V.; Lobovkina, T.; Zare, R. N.; Gambhir, S. S. Nanoparticle PEGylation for Imaging and Therapy Nanomedicine 2011, 6, 715-728
9. Kamaly, N.; Xiao, Z.; Valencia, P. M.; Radovic-Moreno, A. F.; Farokhzad, O. C. Targeted Polymeric Therapeutic Nanoparticles: Design, Development and Clinical Translation Chem. Soc. Rev. 2012, 41, 2971-3010
10. Matsumura, Y. Poly (Amino Acid) Micelle Nanocarriers in Preclinical and Clinical Studies Adv. Drug Delivery Rev. 2008, 60, 899-914
11. Haxton, K. J.; Burt, H. M. Polymeric Drug Delivery of Platinum-Based Anticancer Agents J. Pharm. Sci. 2009, 98, 2299-2316
12. Hoang, B.; Lee, H.; Reilly, R. M.; Allen, C. Noninvasive Monitoring of the Fate of 111In-Labeled Block Copolymer Micelles by High Resolution and High Sensitivity MicroSPECT/CT Imaging Mol. Pharm. 2009, 6, 581-592
13. Plummer, R.; Wilson, R. H.; Calvert, H.; Boddy, A. V.; Griffin, M.; Sludden, J.; Tilby, M. J.; Eatock, M.; Pearson, D. G.; Ottley, C. J. et al. A Phase I Clinical Study of Cisplatin-Incorporated Polymeric Micelles (NC-6004) in Patients with Solid Tumors Br. J. Cancer 2011, 104, 593-598
14. Xu, P.; VanKirk, E. A.; Murdoch, W. J.; Zhan, Y.; Isaak, D. D.; Radosz, M.; Shen, Y. Anticancer Efficacies of Cisplatin-Releasing pH-Responsive Nanoparticles Biomacromolecules 2006, 7, 829-835
15. Yokoyama, M.; Okano, T.; Sakurai, Y.; Suwa, S.; Kataoka, K. Development of the Polymer Micelle Carrier System for Doxorubicin J. Controlled Release 1996, 39, 351-356
16. Johnstone, T. C.; Kulak, N.; Pridgen, E. M.; Farokhzad, O. C.; Langer, R.; Lippard, S. J. Nanoparticle Encapsulation of Mitaplatin and the Effect Thereof on in Vivo Properties ACS Nano 2013, 10.1021/nn401905g
17. Wang, R.; Hu, X.; Xiao, H.; Xie, Z.; Huang, Y.; Jing, X. Polymeric Dinuclear Platinum(II) Complex Micelles for Enhanced Antitumor Activity J. Mater. Chem. B 2013, 1, 744-748
18. Cabral, H.; Nishiyama, N.; Okazaki, S.; Koyama, H.; Kataoka, K. Preparation and Biological Properties of Dichloro(1,2-diaminocyclohexane) platinum(II) (DACHPt)-Loaded Polymeric Micelles J. Controlled Release 2005, 101, 223-232
19. Nowotnik, D. P.; Cvitkovic, E. ProLindac (AP5346): A Review of the Development of an HPMA DACH Platinum Polymer Therapeutic Adv. Drug Delivery Rev. 2009, 61, 1214-1219
20. Maggioni, D.; Fenili, F.; D'Alfonso, L.; Donghi, D.; Panigati, M.; Zanoni, I.; Marzi, R.; Manfredi, A.; Ferruti, P.; D'Alfonso, G. et al. Luminescent Rhenium and Ruthenium Complexes of an Amphoteric Poly(amidoamine) Functionalized with 1,10-Phenanthroline Inorg. Chem. 2012, 51, 12776-12788
21. Konno, T.; Maeda, H.; Iwai, K.; Tashiro, S.; Maki, S.; Morinaga, T.; Mochinaga, M.; Hiraoka, T.; Yokoyama, I. Effect of Arterial Administration of High-Molecular-Weight Anticancer Agent SMANCS with Lipid Lymphographic Agent on Hepatoma: A Preliminary Report Eur. J. Cancer Clin. Oncol. 1983, 19, 1053-1065
22. Wang, X.; Guo, Z. Targeting and Delivery of Platinum-Based Anticancer Drugs Chem. Soc. Rev. 2013, 42, 202-224
23. Bareford, L. M.; Swaan, P. W. Endocytic Mechanisms for Targeted Drug Delivery Adv. Drug Delivery Rev. 2007, 59, 748-758
24. Butler, J. S.; Sadler, P. J. Targeted Delivery of Platinum-Based Anticancer Complexes Cur. Opin. Chem. Biol. 2013, 17, 175-188
25. Geng, Y.; Dalhaimer, P.; Cai, S.; Tsai, R.; Tewari, M.; Minko, T.; Discher, D. E. Shape Effects of Filaments versus Spherical Particles in Flow and Drug Delivery Nat. Nanotechnol. 2007, 2, 249-255